{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:38:11Z","timestamp":1789148291656,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00436-025-08453-9","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T02:07:25Z","timestamp":1737684445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Immunomodulatory activity of Trypanosoma cruzi recombinant antigen combination TSA-1-C4 and Tc24-C4 induce activation of macrophages and CD8+ T cells"],"prefix":"10.1007","volume":"124","author":[{"given":"Victor Manuel","family":"Dzul-Huchim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Rosado-Vallado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Euan-Canto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Torres-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Ortega-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio Vladimir","family":"Cruz-Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana Estefania","family":"Villanueva-Lizama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Arana-Arg\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"key":"8453_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08820139.2020.1810703","volume":"24","author":"VE Arana-Arg\u00e1ez","year":"2020","unstructured":"Arana-Arg\u00e1ez VE, Ceballos-G\u00f3ngora E, Alvarez-S\u00e1nchez ME, Euan-Canto A, Lara-Riegos J, Torres-Romero J et al (2020) In vitro activation of macrophages by an MHC class II-restricted Trichomonas vaginalis TvZIP8-derived synthetic peptide. Immunol Invest 24:1\u201315. https:\/\/doi.org\/10.1080\/08820139.2020.1810703","journal-title":"Immunol Invest"},{"key":"8453_CR2","doi-asserted-by":"publisher","unstructured":"Arana-Arg\u00e1ez V, Alonso-Castro AJ, Y\u00e1\u00f1ez-Barrientos E, Euan-Canto A, Torres-Romero JC, Isiordia-Espinoza MA, et al (2021) In vitro and in vivo anti-inflammatory effects of an ethanol extract from the aerial parts of Eryngium carlinae F. Delaroche (Apiaceae). J Ethnopharmacol 10;266:113406. https:\/\/doi.org\/10.1016\/j.jep.2020.113406","DOI":"10.1016\/j.jep.2020.113406"},{"key":"8453_CR3","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3389\/fimmu.2014.00491","volume":"5","author":"G Arango-Duque","year":"2014","unstructured":"Arango-Duque G, Descoteaux A (2014) Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol 5:491. https:\/\/doi.org\/10.3389\/fimmu.2014.00491","journal-title":"Front Immunol"},{"issue":"4","key":"8453_CR4","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1080\/21645515.2015.1119346","volume":"12","author":"MA Barry","year":"2016","unstructured":"Barry MA, Wang Q, Jones KM, Heffernan MJ, Buhaya MH, Beaumier CM et al (2016) A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB\/c mouse model of Chagas disease. Hum Vaccin Immunother 12(4):976\u2013987. https:\/\/doi.org\/10.1080\/21645515.2015.1119346","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"8453_CR5","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1172\/JCI34431","volume":"8","author":"GM Barton","year":"2008","unstructured":"Barton GM (2008) A calculated response: control of inflammation by the innate immune system. J Clin Invest 8(2):413\u2013420. https:\/\/doi.org\/10.1172\/JCI34431","journal-title":"J Clin Invest"},{"issue":"2","key":"8453_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.tox.2004.11.035","volume":"208","author":"L Bosc\u00e1","year":"2005","unstructured":"Bosc\u00e1 L, Zeini M, Trav\u00e9s PG, Hortelano S (2005) Nitric oxide and cell viability in inflammatory cells: a role for NO in macrophage function and fate. Toxicol 208(2):249\u2013258. https:\/\/doi.org\/10.1016\/j.tox.2004.11.035","journal-title":"Toxicol"},{"key":"8453_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.734229","volume":"12","author":"M Canton","year":"2021","unstructured":"Canton M, S\u00e1nchez-Rodr\u00edguez R, Spera I, Venegas FC, Favia M, Viola A et al (2021) Reactive oxygen species in macrophages: sources and targets. Front Immunol 12. https:\/\/doi.org\/10.3389\/fimmu.2021.734229","journal-title":"Front Immunol"},{"key":"8453_CR8","doi-asserted-by":"publisher","unstructured":"Cruz-Chan JV, Villanueva-Lizama LE, Versteeg L, Damania A, Villar MJ, Gonzalez-Lopez C, et al (2021) Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection. Sci Rep 5;11(1):3222. https:\/\/doi.org\/10.1038\/s41598-021-82930-w","DOI":"10.1038\/s41598-021-82930-w"},{"key":"8453_CR9","doi-asserted-by":"publisher","unstructured":"Cuervo H, Pineda MA, Aoki MP, Gea S, Fresno M, Girones M (2008) Inducible nitric oxide synthase and arginase expression in heart tissue during acute Trypanosoma cruzi infection in mice: arginase I is expressed in infiltrating CD68+ macrophages. J Infect Dis 15;197(12):1772\u201382. https:\/\/doi.org\/10.1086\/529527","DOI":"10.1086\/529527"},{"issue":"10","key":"8453_CR10","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1128\/IAI.01459-08","volume":"77","author":"BC de Alencar","year":"2009","unstructured":"de Alencar BC, Persechini PM, Haolla FA, de Oliveira G, Silverio JC, Llanes-Vieira J et al (2009) Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination. Infect Immun 77(10):4383\u20134395. https:\/\/doi.org\/10.1128\/IAI.01459-08","journal-title":"Infect Immun"},{"issue":"1","key":"8453_CR11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1080\/21645515.2018.1520581","volume":"15","author":"JJ de la Cruz","year":"2019","unstructured":"de la Cruz JJ, Villanueva-Lizama L, Dzul-Huchim V, Ramirez-Sierra MJ, Martinez-Vega PP, Rosado-Vallado ME et al (2019) Production of recombinant TSA-1 and evaluation of its potential for the immuno-therapeutic control of Trypanosoma cruzi infection in mice. Hum Vaccin Immunother 15(1):210\u2013219. https:\/\/doi.org\/10.1080\/21645515.2018.1520581","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"8453_CR12","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1161\/01.cir.14.6.1035","volume":"14","author":"E Dias","year":"1956","unstructured":"Dias E, Laranja FS, Miranda A, Nobrega G (1956) Chagas\u2019 disease; a clinical, epidemiologic, and pathologic study. Circulation 14(6):1035\u20131060. https:\/\/doi.org\/10.1161\/01.cir.14.6.1035","journal-title":"Circulation"},{"issue":"9","key":"8453_CR13","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1586\/erv.12.85","volume":"11","author":"E Dumonteil","year":"2012","unstructured":"Dumonteil E, Bottazzi ME, Zhan B, Heffernan M, Jones K, Valenzuela J et al (2012) Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects. Expert Rev Vaccines 11(9):1043\u20131055. https:\/\/doi.org\/10.1586\/erv.12.85","journal-title":"Expert Rev Vaccines"},{"issue":"29","key":"8453_CR14","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.1016\/j.vaccine.2020.05.010","volume":"38","author":"E Dumonteil","year":"2020","unstructured":"Dumonteil E, Herrera C, Tu W, Goff K, Fahlberg M, Haupt E et al (2020) Safety and immunogenicity of a recombinant vaccine against Trypanosoma cruzi in Rhesus macaques. Vaccine 38(29):4584\u20134591. https:\/\/doi.org\/10.1016\/j.vaccine.2020.05.010","journal-title":"Vaccine"},{"key":"8453_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010258","volume":"16","author":"VM Dzul-Huchim","year":"2022","unstructured":"Dzul-Huchim VM, Ramirez-Sierra MJ, Martinez-Vega PP, Rosado-Vallado ME, Arana-argaez VE, Ortega-Lopez J et al (2022) Vaccine-linked chemotherapy with a low dose of benznidazole plus a bivalent recombinant protein vaccine prevents the development of cardiac fibrosis caused by Trypanosoma cruzi in chronically-infected BALB\/c mice. PLoS Negl Trop Dis 16. https:\/\/doi.org\/10.1371\/journal.pntd.0010258","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"8453_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004555","volume":"10","author":"GR Goes","year":"2016","unstructured":"Goes GR, Rocha PS, Diniz AR, Aguilar PH, Machado CR, Viera LQ (2016) Trypanosoma cruzi needs a signal provided by reactive oxygen species to infect macrophages. PLoS Negl Trop Dis 10(4). https:\/\/doi.org\/10.1371\/journal.pntd.0004555","journal-title":"PLoS Negl Trop Dis"},{"key":"8453_CR17","doi-asserted-by":"publisher","first-page":"6445","DOI":"10.1016\/j.vaccine.2022.09.068","volume":"40","author":"C Gonz\u00e1lez-L\u00f3pez","year":"2022","unstructured":"Gonz\u00e1lez-L\u00f3pez C, Chen W, Alfaro-Chac\u00f3n A, Villanueva-Lizama LE, Rosado Vallado ME, Ramirez-Sierra MJ et al (2022) A novel multi-epitope recombinant protein elicits an antigen-specific CD8+ T cells response in Trypanosoma cruzi-infected mice. Vaccine 40:6445\u20136449. https:\/\/doi.org\/10.1016\/j.vaccine.2022.09.068","journal-title":"Vaccine"},{"issue":"5","key":"8453_CR18","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1645\/17-7","volume":"103","author":"SM Gunter","year":"2017","unstructured":"Gunter SM, Jones KM, Seid CA, Essigmann H, Zhan B, Strych U et al (2017) Mutations to cysteine residues in the Trypanosoma cruzi B-cell superantigen Tc24 diminish susceptibility to IgM-mediated hydrolysis. J Parasitol 103(5):579\u2013583. https:\/\/doi.org\/10.1645\/17-7","journal-title":"J Parasitol"},{"key":"8453_CR19","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1086\/656917","volume":"10","author":"Y Jackson","year":"2010","unstructured":"Jackson Y, Alirol E, Getaz L, Wolff H, Combescure C, Chappuis F (2010) Tolerance and safety of nifurtimox in patients with chronic chagas disease. Clin Infect Dis 10:e69\u2013e75. https:\/\/doi.org\/10.1086\/656917","journal-title":"Clin Infect Dis"},{"issue":"4","key":"8453_CR20","doi-asserted-by":"publisher","first-page":"e00876","DOI":"10.1128\/IAI.00876-17","volume":"86","author":"KM Jones","year":"2018","unstructured":"Jones KM, Versteeg L, Damania A, Keegan B, Kendricks A, Pollet J et al (2018) Vaccine-linked chemotherapy improves benznidazole efficacy for acute Chagas disease. Infect Immun 86(4):e00876-e917. https:\/\/doi.org\/10.1128\/IAI.00876-17","journal-title":"Infect Immun"},{"key":"8453_CR21","doi-asserted-by":"publisher","first-page":"1106315","DOI":"10.3389\/fcimb.2023.1106315","volume":"13","author":"KM Jones","year":"2023","unstructured":"Jones KM, Mangin EN, Reynolds CL, Villanueva-Lizama LE, Cruz-Chan JV, Versteeg L et al (2023) Vaccine-linked chemotherapy improves cardiac structure and function in a mouse model of chronic Chagas disease. Front Cell Infect Microbiol 13:1106315. https:\/\/doi.org\/10.3389\/fcimb.2023.1106315","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"8453_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1046\/j.1365-3024.1998.00154.x","volume":"20","author":"S Kumar","year":"1998","unstructured":"Kumar S, Tarleton RL (1998) The relative contribution of antibody production and CD8+ T cell function to immune control of Trypanosoma cruzi. Parasite Immunol 20(5):207\u2013216. https:\/\/doi.org\/10.1046\/j.1365-3024.1998.00154.x","journal-title":"Parasite Immunol"},{"issue":"7","key":"8453_CR23","doi-asserted-by":"publisher","first-page":"4596","DOI":"10.4049\/jimmunol.166.7.4596","volume":"166","author":"S Kumar","year":"2001","unstructured":"Kumar S, Tarleton RL (2001) Antigen-specific Th1 but not Th2 cells provide protection from lethal Trypanosoma cruzi infection in mice. J Immunol 166(7):4596\u20134603. https:\/\/doi.org\/10.4049\/jimmunol.166.7.4596","journal-title":"J Immunol"},{"issue":"4","key":"8453_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003693","volume":"9","author":"M Maciel","year":"2015","unstructured":"Maciel M, da Sil P-C, Cordeiro M, da Motta M, Cassemiro K, Maia R.deC, et al (2015) A DNA vaccine against yellow fever virus: development and evaluation. PLoS Negl Trop Dis 9(4). https:\/\/doi.org\/10.1371\/journal.pntd.0003693","journal-title":"PLoS Negl Trop Dis"},{"key":"8453_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev.immunol.15.1.323","volume":"15","author":"J MacMicking","year":"1997","unstructured":"MacMicking J, Xie QW, Nathan C (1997) Nitric oxide and macrophage function. Annu Rev Immunol 15:323\u2013350. https:\/\/doi.org\/10.1146\/annurev.immunol.15.1.323","journal-title":"Annu Rev Immunol"},{"key":"8453_CR26","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.0105-2896.2004.00183.x","volume":"201","author":"D Martin","year":"2004","unstructured":"Martin D, Tarleton R (2004) Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection. Immunol Rev 201:304\u2013317. https:\/\/doi.org\/10.1111\/j.0105-2896.2004.00183.x","journal-title":"Immunol Rev"},{"issue":"36","key":"8453_CR27","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1016\/j.vaccine.2015.07.017","volume":"33","author":"V Martinez-Campos","year":"2015","unstructured":"Martinez-Campos V, Martinez-Vega P, Ramirez-Sierra MJ, Rosado-Vallado ME, Seid CA, Hudspeth EM et al (2015) Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice. Vaccine 33(36):4505\u20134512. https:\/\/doi.org\/10.1016\/j.vaccine.2015.07.017","journal-title":"Vaccine"},{"issue":"5","key":"8453_CR28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nri3423","volume":"13","author":"C Nathan","year":"2013","unstructured":"Nathan C, Cunningham-Bussel A (2013) Beyond oxidative stress: an immunologist\u2019s guide to reactive oxygen species. Nat Rev Immunol 13(5):349\u2013361.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"8453_CR29","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1038\/npjamd.2016.18","volume":"28","author":"Y Oishi","year":"2016","unstructured":"Oishi Y, Manabe I (2016) Macrophages in age-related chronic inflammatory diseases. NPJ Aging Mech Dis 28(2):16018. https:\/\/doi.org\/10.1038\/npjamd.2016.18","journal-title":"NPJ Aging Mech Dis"},{"key":"8453_CR30","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.coi.2009.07.006","volume":"4","author":"AM Padilla","year":"2009","unstructured":"Padilla AM, Bustamante JM, Tarleton RL (2009) CD8+ T cells in Trypanosoma cruzi infection. Curr Opin Immunol 4:385\u2013390. https:\/\/doi.org\/10.1016\/j.coi.2009.07.006","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"8453_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006928","volume":"14","author":"CN Paiva","year":"2018","unstructured":"Paiva CN, Medei E, Bozza MT (2018) ROS and Trypanosoma cruzi: fuel to infection, poison to the heart. PLoS Pathog 14(4). https:\/\/doi.org\/10.1371\/journal.ppat.1006928","journal-title":"PLoS Pathog"},{"key":"8453_CR32","doi-asserted-by":"publisher","unstructured":"Parodi C, Padilla AM, Basombr\u00edo MA (2009) Protective immunity against Trypanosoma cruzi. Mem Inst Oswaldo Cruz 104Suppl1:288\u201394. https:\/\/doi.org\/10.1590\/s0074-02762009000900038","DOI":"10.1590\/s0074-02762009000900038"},{"issue":"1","key":"8453_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004594","volume":"11","author":"IR Pereira","year":"2015","unstructured":"Pereira IR, Vilar-Pereira G, Marques V, da Silva AA, Caetano B, Moreira OC et al (2015) A human type 5 adenovirus-based Trypanosoma cruzi therapeutic vaccine re-programs immune response and reverses chronic cardiomyopathy. PLoS Pathog 11(1). https:\/\/doi.org\/10.1371\/journal.ppat.1004594","journal-title":"PLoS Pathog"},{"issue":"2","key":"8453_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0022-1759(81)90138-1","volume":"46","author":"E Pick","year":"1981","unstructured":"Pick E, Mizel D (1981) Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J Immunol Methods 46(2):211\u2013226. https:\/\/doi.org\/10.1016\/0022-1759(81)90138-1","journal-title":"J Immunol Methods"},{"key":"8453_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.crimmu.2023.100066","volume":"4","author":"C Poveda","year":"2023","unstructured":"Poveda C, Le\u00e3o A, Mancino C, Taraballi F, Chen Y, Adhikari R et al (2023) Heterologous mRNA-protein vaccination with Tc24 induces a robust cellular immune response against Trypanosoma cruzi, characterized by an increased level of polyfunctional CD8+ T-cells. Current Research in Immunology 4. https:\/\/doi.org\/10.1016\/j.crimmu.2023.100066","journal-title":"Current Research in Immunology"},{"key":"8453_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2022.106334","volume":"229","author":"E Prochetto","year":"2022","unstructured":"Prochetto E, Bontempi I, Rodeles L, Cabrera G, Vicco M, Cacik P et al (2022) Assessment of a combined treatment with a therapeutic vaccine and benznidazole for the Trypanosoma cruzi chronic infection. Acta Trop 229. https:\/\/doi.org\/10.1016\/j.actatropica.2022.106334","journal-title":"Acta Trop"},{"issue":"9723","key":"8453_CR37","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","volume":"375","author":"A Rassi Jr","year":"2010","unstructured":"Rassi A Jr, Rassi A, Marin-Neto JA (2010) Chagas disease. Lancet 375(9723):1388\u20131402. https:\/\/doi.org\/10.1016\/S0140-6736(10)60061-X","journal-title":"Lancet"},{"issue":"10","key":"8453_CR38","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nrcardio.2012.109","volume":"9","author":"AL Ribeiro","year":"2012","unstructured":"Ribeiro AL, Nunes MP, Teixeira MM, Rocha MO (2012) Diagnosis and management of Chagas disease and cardiomyopathy. Nat Rev Cardiol 9(10):576\u2013589. https:\/\/doi.org\/10.1038\/nrcardio.2012.109","journal-title":"Nat Rev Cardiol"},{"key":"8453_CR39","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/507874","volume":"2012","author":"MM Rodrigues","year":"2012","unstructured":"Rodrigues MM, Oliveira AC, Bellio M (2012) The immune response to Trypanosoma cruzi: role of toll-like receptors and perspectives for vaccine development. J Parasitol Res 2012. https:\/\/doi.org\/10.1155\/2012\/507874","journal-title":"J Parasitol Res"},{"issue":"12","key":"8453_CR40","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.22038\/IJBMS.2019.14051","volume":"22","author":"G Salehi-Sangani","year":"2019","unstructured":"Salehi-Sangani G, Mohebali M, Jajarmi V, Khamesipour A, Bandehpour M, Mahmoudi M et al (2019) Immunization against Leishmania major infection in BALB\/c mice using a subunit-based DNA vaccine derived from TSA, LmSTI1, KMP11, and LACK predominant antigens. Iran J Basic Med Sci 22(12):1493\u20131501. https:\/\/doi.org\/10.22038\/IJBMS.2019.14051","journal-title":"Iran J Basic Med Sci"},{"key":"8453_CR41","doi-asserted-by":"publisher","unstructured":"Sathler-Avelar R, Vitelli-Avelar DM, Teixeira-Carvalho A, Martins-Filho OA (2009) Innate immunity and regulatory T-cells in human Chagas disease: what must be understood? Mem Inst Oswaldo Cruz 104Suppl1:246\u201351. https:\/\/doi.org\/10.1590\/s0074-02762009000900031.","DOI":"10.1590\/s0074-02762009000900031"},{"issue":"3","key":"8453_CR42","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1080\/21645515.2016.1242540","volume":"13","author":"CA Seid","year":"2017","unstructured":"Seid CA, Jones KM, Pollet J, Keegan B, Hudspeth E, Hammond M et al (2017) Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease. Hum Vaccin Immunother 13(3):621\u2013633. https:\/\/doi.org\/10.1080\/21645515.2016.1242540","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"8453_CR43","doi-asserted-by":"publisher","first-page":"7391","DOI":"10.3892\/ol.2017.7169","volume":"14","author":"C Si","year":"2017","unstructured":"Si C, Xu M, Lu M, Yu Y, Yang M, Yan M et al (2017) In vivo antitumor activity evaluation of cancer vaccines prepared by various antigen forms in a murine hepatocellular carcinoma model. Oncol Lett 14(6):7391\u20137397. https:\/\/doi.org\/10.3892\/ol.2017.7169","journal-title":"Oncol Lett"},{"issue":"9","key":"8453_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0256980","volume":"16","author":"MJ Sklar","year":"2021","unstructured":"Sklar MJ, Maiolatesi S, Patterson N, Sedegah M, Limbach K, Teneza-Mora N et al (2021) A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-na\u00efve adults. PLoS ONE 16(9). https:\/\/doi.org\/10.1371\/journal.pone.0256980","journal-title":"PLoS ONE"},{"issue":"3","key":"8453_CR45","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1189\/jlb.0504272","volume":"76","author":"RD Stout","year":"2004","unstructured":"Stout RD, Suttles J (2004) Functional plasticity of macrophages: reversible adaptation to changing microenvironments. Journ Leuk Biol 76(3):509\u2013513. https:\/\/doi.org\/10.1189\/jlb.0504272","journal-title":"Journ Leuk Biol"},{"issue":"3","key":"8453_CR46","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00281-015-0481-9","volume":"37","author":"RL Tarleton","year":"2015","unstructured":"Tarleton RL (2015) CD8+ T cells in Trypanosoma cruzi infection. Semin Immunopathol 37(3):233\u2013238. https:\/\/doi.org\/10.1007\/s00281-015-0481-9","journal-title":"Semin Immunopathol"},{"issue":"2","key":"8453_CR47","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/infdis\/jiu418","volume":"211","author":"C Teh-Poot","year":"2015","unstructured":"Teh-Poot C, Tzec-Arjona E, Mart\u00ednez-Vega P, Ramirez-Sierra MJ, Rosado-Vallado ME, Dumonteil E (2015) From genome screening to creation of vaccine against Trypanosoma cruzi by use of immunoinformatics. J Infect Dis 211(2):258\u2013266. https:\/\/doi.org\/10.1093\/infdis\/jiu418","journal-title":"J Infect Dis"},{"issue":"6","key":"8453_CR48","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/s1471-4922(02)02283-3","volume":"18","author":"MM Teixeira","year":"2002","unstructured":"Teixeira MM, Gazzinelli RT, Silva JS (2002) Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol 18(6):262\u2013265. https:\/\/doi.org\/10.1016\/s1471-4922(02)02283-3","journal-title":"Trends Parasitol"},{"issue":"4","key":"8453_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002658","volume":"8","author":"J Tosello-Boari","year":"2012","unstructured":"Tosello-Boari J, Amezcua-Vesely MC, Bermejo DA, Ramello MC, Montes CL, Cejas H et al (2012) IL-17RA signaling reduces inflammation and mortality during Trypanosoma cruzi infection by recruiting suppressive IL-10-producing neutrophils. PLoS Pathog 8(4). https:\/\/doi.org\/10.1371\/journal.ppat.1002658","journal-title":"PLoS Pathog"},{"issue":"9","key":"8453_CR50","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.3389\/fimmu.2018.02347","volume":"11","author":"J Tosello-Boari","year":"2018","unstructured":"Tosello-Boari J, Araujo Furlan CL, Fiocca Vernengo F, Rodrigues C, Ramello MC, Amezcua-Vesely MC et al (2018) IL-17RA-signaling modulates CD8+ T cell survival and exhaustion during Trypanosoma cruzi infection. Front Immunol 11(9):2347. https:\/\/doi.org\/10.3389\/fimmu.2018.02347","journal-title":"Front Immunol"},{"key":"8453_CR51","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.actatropica.2009.10.023","volume":"1\u20132","author":"JA Urbina","year":"2010","unstructured":"Urbina JA (2010) Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches. Act Trop 1\u20132:55\u201368. https:\/\/doi.org\/10.1016\/j.actatropica.2009.10.023","journal-title":"Act Trop"},{"key":"8453_CR52","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jep.2016.06.006","volume":"190","author":"FE Villa de la Torre","year":"2016","unstructured":"Villa de la Torre FE, Ralf K, Gabriel B, Arana-Argaez VE, Martha MG, Mirbella CF et al (2016) Anti-inflammatory and immunomodulatory effects of Critonia aromatisans leaves: downregulation of pro-inflammatory cytokines. J Ethnopharmacol 190:174\u2013182. https:\/\/doi.org\/10.1016\/j.jep.2016.06.006","journal-title":"J Ethnopharmacol"},{"key":"8453_CR53","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1586\/14787210.7.2.157","volume":"2","author":"R Viotti","year":"2009","unstructured":"Viotti R, Vigliano C, Lococo B, Alvarez MG, Petti M, Bertocchi G et al (2009) Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities. Expert Rev Anti Infect Ther 2:157\u2013163. https:\/\/doi.org\/10.1586\/14787210.7.2.157","journal-title":"Expert Rev Anti Infect Ther"},{"key":"8453_CR54","unstructured":"World Health Organization (2018) Chagas disease (American trypanosomiasis)- global distribution of cases of Chagas disease based on official stimates on 2018 https:\/\/www.who.int\/health-topics\/chagas-disease#tab=tab_1. Accessed 14 november 2024"},{"issue":"4","key":"8453_CR55","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1080\/09540105.2013.858311","volume":"25","author":"RS Zamani-Taghizadeh","year":"2014","unstructured":"Zamani-Taghizadeh RS, Mahmoudi M, Ahmadsimab H, Zamani-Taghizadeh R, Emami A (2014) Investigation of the biological activity of methanol extract from Eremostachys labiosa Bunge. Food Agricult Immunol 25(4):578\u2013585. https:\/\/doi.org\/10.1080\/09540105.2013.858311","journal-title":"Food Agricult Immunol"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-025-08453-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00436-025-08453-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-025-08453-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T04:35:17Z","timestamp":1738384517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00436-025-08453-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["8453"],"URL":"https:\/\/doi.org\/10.1007\/s00436-025-08453-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4764016\/v1","asserted-by":"object"}]},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"18 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All studies were approved by the institutional bioethics committee of the \u201cCentro de Investigaciones Regionales Dr. Hideyo Noguchi,\u201d, Universidad Aut\u00f3noma de Yucat\u00e1n (Reference #CEI-08-2019) and were maintained in accordance with the principles and guidelines of National Institutes of Health Guide for Treatment and Care for Laboratory Animals and by the Mexican Official Norm for Animal Care and Handing,NOM\u2010062\u2010ZOO\u20101999.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"12"}}